Histone Deacetylase Inhibitor class drugs

1 result
Acrotech Biopharma Inc
Usage: Beleodaq is indicated for adults with relapsed or refractory peripheral T-cell lymphoma (PTCL). Its approval is under accelerated conditions based on tumor response and duration, without established improvements in survival or symptoms. Continued approval may depend on further verification of clinical benefits.